By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2nd Cell Therapy Potency Assay Summit aims to help experts improve their approach to potency assay development in order to align with clinical outcomes and regulatory guidelines. Over 100 professionals will gather to discuss how to design better potency assays that are scientifically rigorous and informative, with the goal of minimizing hold times and achieving regulatory approval.Whether you're preparing for your first IND submission or getting ready for a BLA submission, this meeting is an excellent opportunity to learn from industry leaders like bluebird bio, Arsenal Bio, Takeda, Merck, and Sana Biotechnology. Participants will receive updates on regulatory interactions and gain insight into how their peers are approaching potency assay development.Attendees will leave the summit with a better understanding of how to develop practical, compatible, and reproducible potency assays, and how to better characterize their cell therapy products for targeted and untargeted platforms in oncology and non-oncology indications, whether they are allogeneic or autologous.
Advance your knowledge of cell therapy potency assay and connect with industry experts.
Streamline regulatory approval. Gain critical updates on regulatory interactions & unpick how industry peers are approaching potency assay development.
Attend presentations, panel discussions, and networking events to gain practical insights and new perspectives to further your research.
Revolutionize your approach to potency assay development to align with the clinical outcome & regulatory guidelines confidently.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands.
At Axion BioSystems, our goal is to provide advanced live-cell assay systems that allow you to noninvasively evaluate your cells.
We're an advanced genomic services company offering assays compliant with FDA and EPA enforced regulations to assist our customers in their regulatory submissions.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
At Samplix, we’ve developed a unique microfluidics instrument called Xdrop, which enables rapid and accurate functional analysis of cells with single-cell resolution.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.